Mylan N.V. (MYL) ROE - Return on Equity

Current and historical Return on Equity (ROE) values for Mylan N.V. (MYL) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $20.036B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.